Navigation Links
CME LLC Announces the Launch of the CME Activity Advances in the Management of Major Depressive Disorders
Date:1/18/2012

JERSEY CITY, N.J., Jan. 18, 2012 /PRNewswire/ -- CME LLC has officially launched an online educational activity titled "Advances in the Management of Major Depressive Disorders" on http://www.cmellc.com. Developed for psychiatrists, primary care physicians, nurses, and other health care professionals, this Case Challenge activity is intended to provide possible treatment options and individualized management approaches, including the augmentation of antidepressant therapy with folate formulations, for consideration when treating patients with major depressive disorder (MDD) in order to provide optimal patient outcomes. This activity is supported by an educational grant from Pamlab, L.L.C.

C. Brendan Montano, MD, the Director of Research at Connecticut Clinical Research, in Cromwell, Connecticut and Richard C. Shelton, MD, a James G. Blakemore Professor in the Department of Psychiatry, Professor in Departments of Psychology and Pharmacology, and Vice-Chair of Clinical Research at Vanderbilt University School of Medicine in Nashville, Tennessee comprise the faculty for the activity.

Cased-based methods of learning are extremely effective in getting across educational messages and demonstrating practical strategies. In this Case Challenge activity, participants are encouraged to determine treatment strategies based on case histories and patient presentations. "Non-response to antidepressant therapy, as defined by the presence or absence of full recovery of depression, is the rule rather than the exception for the treatment of depression, even in the primary care setting. This CME activity presents real-world examples of the management of depression to full remission. As such, I think it will provide practitioners practical strategies for managing depression to wellness." – Richard C. Shelton

Upon completion of the activity, participants should be able to:

  • Utilize evidence-based strategies to best sequence administration of antidepressant therapy with adjunctive therapies to enhance response rates and achieve remission
  • Compare and contrast the long-term efficacy, safety, and tolerability of adjunctive therapies indicated for depression to better individualize therapy
  • Understand the relationship between folate and depression, including the contribution of folate to monoamine deficiencies, to determine patient type
  • Review currently available sources of folate supplementation and their potential role in MDD management

The online activity is CME-certified and approved for nursing contact hours.  It will be available through October 31, 2012. 

About CME LLC

CME LLC develops educational plans designed to meet the needs of practicing clinicians based on demonstrated gaps within a target audience. Individual activities focus on maintaining, developing, or increasing the knowledge, skills, competence, and professional performance of clinicians to improve patient care. Founded in 1978 with the vision to provide high-quality, practical medical education and information for mental health clinicians, CME LLC's reach now expands to educational offerings for primary care, oncology, and practice management professionals in various formats including live events, print formats, interactive online activities and more.

Continuing Education Credit

CME LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CME LLC designates this enduring activity for a 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider Number CEP12748 for 1 contact hour.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion, as AAPA, AANP and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Contact: Michael DeMilt
CME LLC
201.984.6224 phone
201.336.6497 fax
michael.demilt@ubm.com


'/>"/>
SOURCE CME LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... , May 26, 2016 According ... "Medical Waste Management Market - U.S. Industry Analysis, Size, Share, ... management market in the U.S. was valued at US$ 5.89 ... CAGR of 3.4% from 2015 to 2023 to reach US$ ... analysis of current and emerging needle free drug delivery devices ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
(Date:5/26/2016)... Since its commercial introduction in ... life science tool for conducting genetic studies in a ... in its new report that the industry sits on ... by a range of new applications in the clinical ... http://photos.prnewswire.com/prnh/20140723/694805 ) , Since the Human ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... 31, 2016 , ... More than 80 representatives of the Hepatitis B ... Cancer Foundation held an event on National Hepatitis Testing Day outside of Philadelphia City ... the leading cause of liver cancer. , Foundation leaders and the citywide coalition they ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... mix of advanced Artificial Intelligence (AI) and the latest in Clinical Patient ... center is integrating predictive analytic outputs directly into the clinical workflow. These insights ...
(Date:5/31/2016)... ... May 31, 2016 , ... Effective leaders not only drive service to the ... whole. On June 2, Northbound CEO Mike Neatherton and COO Paul Alexander will be ... opening plenary on “Leadership: The Journey to Authenticity” with Onsite Workshops CEO Miles Adcock ...
(Date:5/31/2016)... ... 31, 2016 , ... In his latest video, renowned AstroNumerologist ... humans. Using presidential candidate Donald Trump as an example, Kalsi describes the way ... not about adding numbers up,” says Kalsi. “It is about looking at each ...
(Date:5/31/2016)... ... 31, 2016 , ... TeaZa® Energy, LLC announces the launch of ... No Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be available to customers ... , The new flavor is best described as a juicy, taste bud takeover. ...
Breaking Medicine News(10 mins):